Phenotap, Inc. Receives Program Related Investment from the Helmsley Charitable Trust to Advance Breakthrough Ketone Sensor Technology for People Living with Type 1 Diabetes
New York, NY – July 10, 2025 – Phenotap, Inc. today announced it has been awarded $3 million in a Program Related Investment in the form of a loan from...